Cue Biopharma's market cap is currently $86.79M. The company's EPS TTM is $-0.906; its P/E ratio is ―; Cue Biopharma is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 5.49M	$ 1.25M	$ 14.94M	$ 3.15M	$ 3.46M
Gross Profit	$ -32.61M	$ -560.83K	$ 16.72M	$ -30.39M	$ -24.03M
Operating Income	$ -52.15M	$ -53.22M	$ -43.71M	$ -45.04M	$ -36.77M
EBITDA	$ -46.05M	$ -50.49M	$ -45.44M	$ -43.99M	$ -35.96M
Net Income	$ -50.73M	$ -52.80M	$ -44.16M	$ -44.78M	$ -36.70M
Balance Sheet
Cash & Short-Term Investments	$ 48.51M	$ 76.29M	$ 64.37M	$ 84.87M	$ 44.29M
Total Assets	$ 61.53M	$ 91.28M	$ 83.40M	$ 99.53M	$ 71.61M
Total Debt	$ 14.70M	$ 19.32M	$ 10.05M	$ 7.15M	$ 5.80M
Net Debt	$ -33.82M	$ -32.30M	$ -54.32M	$ -67.72M	$ -38.49M
Total Liabilities	$ 24.45M	$ 25.60M	$ 17.91M	$ 20.62M	$ 17.02M
Stockholders' Equity	$ 37.09M	$ 65.68M	$ 65.49M	$ 78.91M	$ 54.58M
Cash Flow
Free Cash Flow	$ -39.96M	$ -41.98M	$ -39.75M	$ -33.09M	$ -30.84M
Operating Cash Flow	$ -39.96M	$ -41.81M	$ -38.84M	$ -32.49M	$ -30.80M
Investing Cash Flow	$ 25.00M	$ -24.61M	$ 9.11M	$ 4.46M	$ 3.45M
Financing Cash Flow	$ 11.86M	$ 53.66M	$ 19.23M	$ 58.61M	$ 50.79M

Currency in USD

Cue Biopharma Earnings and Revenue History

Income Statement >

Cue Biopharma Debt to Assets

Balance Sheet >

Cue Biopharma Cash Flow

Cash Flow >

Cue Biopharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing